MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
28.01
-2.09 (-6.94%)
At close: Jun 5, 2026, 4:00 PM EDT
28.10
+0.09 (0.32%)
Pre-market: Jun 8, 2026, 8:30 AM EDT
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $1.27 billion as of June 8, 2026.
Market Cap
1.27B
Enterprise Value
965.61M
1-Year Change
n/a
Ranking
Category
Stock Price
$28.01
Market Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has increased from $704.29M to $1.27B, an increase of 80.34%. That is a compound annual growth rate of 164.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.27B | 74.54% |
| Dec 31, 2025 | 727.70M | 3.32% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 1.37B |
| Maze Therapeutics | 1.34B |
| MoonLake Immunotherapeutics | 1.32B |
| Bicara Therapeutics | 1.31B |
| Immatics | 1.31B |
| UroGen Pharma | 1.31B |
| Maravai LifeSciences Holdings | 1.30B |
| Damora Therapeutics | 1.29B |